Stay updated with breaking news from Cordella System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
University Hospital Galway (UHG) has completed the final phase of an innovative clinical trial which reduces the hospitalisation rate for patients living with heart failure.
Company also announces publication of the PROACTIVE-HF trial design rationale, the first global IDE trial for PA pressure-guided heart failure management, in the Journal of Cardiac Failure LISLE
/PRNewswire/ -- Endotronix, Inc., a privately-held digital health and medical technology company dedicated to advancing the treatment of heart failure (HF),...
Company also announces publication of the PROACTIVE-HF trial design rationale, the first global IDE trial for PA pressure-guided heart failure man...
/PRNewswire/ -- Endotronix, Inc., a privately-held digital health and medical technology company dedicated to advancing the treatment of heart failure (HF),...